Indefinite Delivery Contract 75N98026D00031
Award Date 7/20/26
Last Date to Order 7/19/31
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Service Contract Act
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed Similar IDVs
- The National Institute on Drug Abuse awarded an Indefinite Delivery Contract to Sri International for chemistry, manufacturing, and controls services in support of drug product development, with a contract ceiling of $49,885,703 and an award date of July 3, 2026. This is a multiple-award IDIQ with no set-aside restriction. Work is performed at the primary location in Potomac, Maryland. The IDIQ supports comprehensive CMC services across small molecules, peptides, biologics, gene therapy vectors,...
- The National Institute on Drug Abuse awarded a multiple-award indefinite-delivery contract to Lovelace Biomedical Research Institute on August 6, 2024, with a ceiling of $48.9 million and ultimate completion date of August 5, 2030. The contract covers pharmacology studies, animal model development, and related services for drug development. Place of performance is Albuquerque, New Mexico. Work under this IDIQ draws from a pre-solicitation opportunity posted November 7, 2022, reflecting the...
- The National Institute on Drug Abuse (NIDA) awarded a $5 million single-award Indefinite Delivery Vehicle (IDV) contract to Eurofins Discovery Services North America, LLC (UEI: HF4LCAU68M93) on September 26, 2023, with performance extending through September 25, 2028. The IDV was designated as a Total Small Business set-aside despite the vendor's later task orders utilizing no small business set-aside designations. Under this vehicle, Eurofins provides receptor binding studies and predictive...
- The National Center for Advancing Translational Sciences (NCATS) awarded a single-award indefinite delivery contract to Mriglobal, doing business as Midwest Research Institute, on May 15, 2024, with a ceiling of $49,713,679 and an ultimate completion date of May 14, 2031. The IDIQ procures chemistry, manufacturing and controls and related services for development of drug substances, with performance at Mriglobal's Kansas City, Missouri headquarters and subordinate operational sites in North...
- The National Institute on Drug Abuse awarded an indefinite-delivery contract to Research Triangle Institute (doing business as RTI International) on June 9, 2022, for the synthesis and distribution of drugs of abuse and related compounds, with a ceiling value of $17.7 million and an ultimate completion date of June 8, 2027. This is a single-award IDIQ with no set-aside designation. Work is performed at RTI International's facility in Durham, North Carolina. The contract employs...
- The National Institute on Drug Abuse awarded a multiple-award indefinite-delivery contract to Advanced Bioscience Laboratories, Inc., with a ceiling of $49,885,703.00 and an award date of August 1, 2024. This IDIQ is structured to provide chemistry, manufacturing, and control (CMC) and related services for drug products, executing under Executive Order 14398. The contract runs through July 31, 2031. Advanced Bioscience Laboratories, Inc., is a contract research and manufacturing organization...
- The National Institute on Drug Abuse awarded a multiple-award indefinite-delivery contract to Advanced Bioscience Laboratories, Inc. with a ceiling of $48,882,666 on August 6, 2024, for pharmacology studies, animal model development, and related services supporting drug development. The contract carries no set-aside designation. Performance occurs at the contractor's facilities with administrative coordination in Rockville, Maryland. The contract runs through August 5, 2030. A kick-off meeting...
- The National Institute on Drug Abuse awarded a single-award indefinite-delivery contract to Concept To Market LLC on May 15, 2024, with a ceiling of $49,713,679 for chemistry, manufacturing and controls and related services for development of drug substances. The contract carries no set-aside designation. Performance extends through May 14, 2031. The originating solicitation, posted April 20, 2023, sought chemistry, manufacturing and controls expertise and related services to support drug...
- This Indefinite Delivery Contract (IDC) was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Technical Resources International, Inc. (TRI), a minority-owned, woman-owned, and Hispanic American-owned small business based in Bethesda, Maryland. The contract, valued at a ceiling of $2,500,000, is for the Pharmacokinetic Analysis Resource Center, which will provide support to clinical pharmacology and...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse (NIDA) awarded a single-award $21 million indefinite delivery contract to Altasciences Clinical Kansas Inc., a contract research organization, to conduct pharmacokinetic and pharmacodynamic trials for medication development in substance use disorders. Under this contract, NIDA issued a $1,838,615 firm fixed price delivery order to Altasciences to perform Phase 1 cocaine drug interaction...
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order 75N98026D00031-75N98026F00002 | Mriglobal | $478.1k | 7/20/26 | 1/19/28 | 7/16/26 | |
Delivery Order 75N98026D00031-75N98026F00001 | Mriglobal | $382.8k | 7/20/26 | 1/19/28 | 7/16/26 |